Can you take omeprazole (Proton Pump Inhibitor) and Pepcid (Famotidine) together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

It is generally not recommended to take omeprazole (a proton pump inhibitor) and famotidine (Pepcid, an H2 blocker) together routinely. These medications work through different mechanisms to reduce stomach acid, and taking them simultaneously is usually unnecessary and may increase the risk of side effects without providing significant additional benefit. Omeprazole works by blocking the proton pumps that produce acid in the stomach, while famotidine blocks histamine receptors that stimulate acid production. If you're taking omeprazole (typically dosed at 20-40mg once daily), it should provide sufficient acid suppression for most conditions.

Some key points to consider:

  • The combination of omeprazole and famotidine may be used in specific clinical situations, such as severe acid hypersecretion disorders, but this should be done under direct medical supervision.
  • Taking both medications could potentially mask symptoms of more serious underlying conditions that need proper evaluation.
  • According to the study 1, the doses of proton pump inhibitors and H2 antagonists are considered equivalent, and the potential for interactions between these medications should be considered.
  • Other studies, such as 1, 1, 1, 1, 1, and 1, provide additional information on the use of proton pump inhibitors and H2 blockers, but the most recent and highest quality study 1 should be prioritized when making a recommendation.

In summary, taking omeprazole and famotidine together is not typically recommended, and patients should consult their healthcare provider before combining these medications.

From the Research

Taking Omeprazole and Pepcid Together

  • Omeprazole is a proton pump inhibitor (PPI) that reduces stomach acid production by binding to hydrogen/potassium-exchanging adenosine triphosphatase in gastric parietal cells 2.
  • Pepcid, also known as famotidine, is a histamine H2-receptor antagonist that also reduces stomach acid production, but through a different mechanism 3.
  • There is evidence to suggest that omeprazole and famotidine can be used together, as they have different mechanisms of action and may be effective in treating different types of acid-related disorders 4, 5.
  • A study comparing omeprazole and famotidine in patients with moderate to severe esophagitis found that omeprazole was more effective in reducing esophageal acid exposure, but famotidine was still effective in improving symptoms 4.
  • Another study found that famotidine and omeprazole were both effective in improving symptoms of non-erosive gastroesophageal reflux disease, although famotidine was more effective in improving abdominal pain and indigestion symptoms 5.

Potential Interactions

  • There is no direct evidence to suggest that taking omeprazole and Pepcid together is contraindicated, but it is always best to consult with a healthcare professional before taking any new medications.
  • Omeprazole can interact with other medications, such as clarithromycin, which can increase omeprazole levels and potentially lead to adverse effects 6.
  • However, the interaction between omeprazole and famotidine is not well-studied, and more research is needed to fully understand the potential effects of taking these medications together.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lansoprazole and omeprazole in the treatment of acid peptic disorders.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1996

Research

Management of Zollinger-Ellison syndrome with gastric antisecretory drugs.

Scandinavian journal of gastroenterology. Supplement, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.